US working with India on Covid-19 vaccine project: Trump
Published By : Prameya News Bureau | May 15, 2020 IST
Share
New York, May 15: Launching "Operation Warp Speed" to ready a vaccine against Covid-19 by the end of the year, President Donald Trump said on Friday the US was working with India on the project. "We are working very closely also with India," Trump said while speaking to reporters when he unveiled the project at the White House. He also acknowledged the work of Indian-Americans on vaccine development projects. There is a "tremendous Indian population in the United States, many of the people you are talking about are working on the vaccine too. Great scientists and researchers," he said. Trump, who recalled his February visit to India, ended his comment on India saying, "Say hello to your Prime Minister!" Earlier, he said that India and other countries would have access to any vaccine or therapy developed by the US. He said that the US and companies were not seeking to make a profit out of the crisis and wanted to make them available to all. Trump said that the goal of "Operation Warp Speed" was to try to have a vaccine ready by the end of the year. "We would love to see if we could do it prior to the end of the year," he said. He said that Moncef Slaoui, who is the former head of GlaxoSmithKline vaccines division, would head the project with General Gustave Perna looking after the logistics. Trump said that the vaccine would be available to all who wanted it and the military, the other arms of the government and the private sector would be fully mobilised to get them out. The best candidates of the several under development would be made ready in advance and would go out as soon one gets approved. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
India marks 4th anniversary of first Covid-19 lockdown
Religious people coped better with Covid pandemic: Study
Covid infection no longer perceived as serious health problem: Study
Mankind Pharma donated Rs 250 cr for Covid relief due to miscalculation
Covid scare: 573 fresh cases in India, two deaths
Health Dept urges people to avoid crowd during New Year celebration
Mushroom derived bioactive compounds have potential to combat COVID-19, viral infections
Delhi Health Minister assesses Covid preparedness amid rising JN.1 variant cases across country
JN.1 variant dominates US with 50% of Covid cases: CDC
No real need for booster vaccination, say experts as JN.1 spreads in India
5 active COVID cases detected in Odisha
Mild earthquake jolts Chhattisgarh, no casualty reported
Fresh Covid cases cross 100-mark in K'taka; positivity rate 5.93%
JN.1 scare: Odisha Health Dept advises elderly people to use facemasks
Spike in Covid cases, 1 death reported in Karnataka
Karnataka reports 20 new Covid-19 cases, 2 deaths
Health Ministry issues advisory on continued Covid vigilance
WHO calls for raising surveillance amid global rise in Covid cases
Drugs to reverse brain ageing caused by Covid
Covid-19 heightens risk of heart attack, stroke: Research